Literature DB >> 7560619

Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I).

N A Omoigui1, R M Califf, K Pieper, G Keeler, M A O'Hanesian, L G Berdan, D B Mark, J D Talley, E J Topol.   

Abstract

OBJECTIVES: In-hospital peripheral vascular complications of balloon angioplasty were compared with those of directional atherectomy in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) to identify patients at risk and evaluate costs and outcomes.
BACKGROUND: The incidence, costs and outcomes of peripheral vascular complications after coronary intervention have not been fully characterized as a function of randomly assigned therapy.
METHODS: At 35 sites in the United States and Europe, 1,012 patients were randomized. Peripheral vascular complications were defined as the composite of pulse loss, pseudoaneurysm, hematoma > 4 cm in diameter or groin hemorrhage necessitating blood transfusion. Logistic models were derived to 1) predict these complications from baseline and procedural characteristics, 2) test the relevance of randomization assignment, and 3) assess their impact on hospital costs and long-term outcomes.
RESULTS: Sixty-seven patients (6.6%) developed peripheral vascular complications, of whom 15 (22.4%) required a blood transfusion, 14 (20.9%) underwent vascular surgery, and 2 (3.0%) died. Both in-hospital deaths occurred in patients with peripheral vascular complications. There was no difference in composite peripheral vascular complication rates among patients randomized to angioplasty or atherectomy. Greater age, female gender, postprocedural heparin and intraaortic balloon counterpulsation were predictive of increased risk. In a representative 60% subset, mean hospital costs increased from $9,583 in patients without to $18,350 in those with peripheral vascular complications (p = 0.0001). The unadjusted mortality rate at 1 year was 7.5% for patients with peripheral vascular complications compared with 1.1% for all others (p = 0.0001). These complications identified patients at greater risk of death, myocardial infarction or repeat revascularization at 30 days and 1 year. The atherectomy group had a trend toward more frequent deaths and myocardial infarction.
CONCLUSIONS: Directional atherectomy and balloon angioplasty had similar in-hospital peripheral vascular complication rates. Female gender, greater age, postprocedural heparin and intraaortic balloon counterpulsation were predictive of higher risk. The twofold increase in cost and sevenfold increase in long-term deaths highlight the need to prevent these periprocedural events and monitor patients closely.

Entities:  

Mesh:

Year:  1995        PMID: 7560619     DOI: 10.1016/0735-1097(95)00263-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

1.  [Hemostatic closure of arterial puncture site using Angio-Seal after diagnostic heart catheterization or coronary intervention].

Authors:  H Eggebrecht; M Haude; D Baumgart; O Oldenburg; J Herrmann; C Bruch; P Hunold; C Neurohr; C von Birgelen; D Welge; M A Katz; R Erbel
Journal:  Herz       Date:  1999-12       Impact factor: 1.443

2.  The problem of protocol driven costs in pharmacoeconomic analysis.

Authors:  D Coyle; K M Lee
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

3.  Safety of low dose heparin in elective coronary angioplasty.

Authors:  K T Koch; J J Piek; R J de Winter; G K David; K Mulder; J G Tijssen; K I Lie
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

4.  Two hour ambulation after coronary angioplasty and stenting with 6 F guiding catheters and low dose heparin.

Authors:  K T Koch; J J Piek; R J de Winter; K Mulder; C E Schotborgh; J G Tijssen; K I Lie
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

5.  Radioembolization complicated by dissection of the common femoral artery.

Authors:  Sarah G Deitch; Ramona Gupta
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

Review 6.  Efficacy and safety of the perclose closer s device after neurointerventional procedures: prospective study and literature review.

Authors:  Kamran Khaghany; Firas Al-Ali; Thomas Spigelmoyer; Ron Pimentel; Kurt Wharton
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

7.  Usefulness of a Nonsuture Closure Device in Patients Undergoing Diagnostic Coronary and Peripheral Angiography.

Authors:  John T Owens; Shaun Bhatty; Robert J Donovan; Andrea Tordini; Peter Danyi; Kalpesh Patel; Jacob A Wegelin; Ion S Jovin
Journal:  Int J Angiol       Date:  2017-10-04

8.  Comparison of Exo-Seal(®) and Angio-Seal (®) for arterial puncture site closure: A randomized, multicenter, single-blind trial.

Authors:  Johannes Ketterle; Harald Rittger; Inga Helmig; Lutz Klinghammer; Stefan Zimmermann; Wolfgang Hohenforst-Schmidt; Johannes Brachmann; Holger Nef; Stephan Achenbach; Christian Schlundt
Journal:  Herz       Date:  2015-06-13       Impact factor: 1.443

9.  Ultrasound-guided thrombin injection versus ultrasound-guided compression repair in the treatment of post-catheterization femoral artery pseudoaneurysm: King Saud University Medical Center Experience.

Authors:  Talal Altuwaijri; Mussaad Alsalman; Abdulamjeed Altoijry; Kaisor Iqbal; Hesham AlGhofili
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-01-23       Impact factor: 0.332

10.  Efficacy of femoral vascular closure devices in patients treated with anticoagulant, abciximab or thrombolytics during percutaneous endovascular procedures.

Authors:  Ha Young Kim; Sung Wook Choo; Hong Gee Roh; Heon Han; Sam Soo Kim; Ji Yeon Lee; Yul Ri Park; Sung Hoon Lee; Sung Wook Shin; Kwang Bo Park; Young Soo Do; Sung Ki Cho; In Ho Lee; Sung Mok Kim; Hong Sik Byun; Pyoung Jeon
Journal:  Korean J Radiol       Date:  2006 Jan-Mar       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.